Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group

Abstract

This is a comprehensive study identifying genomic markers of a good-risk group with prolonged survival. Identification of this patient subgroup will affect future therapeutic algorithms and research planning.